0000000000473570

AUTHOR

M Romano

showing 24 related works from this author

A “Painful Tic Convulsif” (Trigeminal Neuralgia And Ipsilateral Facial Spasm) Due To Double Neuro-Vascular Impingement: A Case Report.

2011

painful tic convulsif trigeminal neuralgia facial spasm neurovascular impingement
researchProduct

Rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART): study protocol for a randomized controlled trial.

2012

Abstract Background Acute respiratory distress syndrome (ARDS) is associated with high in-hospital mortality. Alveolar recruitment followed by ventilation at optimal titrated PEEP may reduce ventilator-induced lung injury and improve oxygenation in patients with ARDS, but the effects on mortality and other clinical outcomes remain unknown. This article reports the rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART). Methods/Design ART is a pragmatic, multicenter, randomized (concealed), controlled trial, which aims to determine if maximum stepwise alveolar recruitment associated with PEEP titration is able to increase 28-day survival in patients with …

Research designARDSmedicine.medical_specialtyTime FactorsVentilator-Induced Lung InjuryAlveolar recruitmentTreatment outcomeRandomizedMedicine (miscellaneous)Settore MED/41 - AnestesiologiaHospital mortalitylaw.inventionPositive-Pressure RespirationStudy ProtocolMechanical ventilationClinical trialsRandomized controlled trialClinical ProtocolslawMedicineHumansPharmacology (medical)Hospital MortalityPEEPProtocol (science)Respiratory Distress SyndromeAcute respiratory distress syndromebusiness.industryrespiratory systemLength of Staymedicine.diseaseClinical trialPulmonary AlveoliARDS; Alveolar recruitment; PEEPIntensive Care UnitsTreatment OutcomeMulticenter studyBarotraumaResearch DesignPhysical therapyARDSbusinessBrazilTrials
researchProduct

Safety and efficacy of non-steroidal anti-inflammatory drugs to reduce ileus after colorectal surgery

2019

Ileus is common after elective colorectal surgery, and is associated with increased adverse events and prolonged hospital stay. The aim was to assess the role of non-steroidal anti-inflammatory drugs (NSAIDs) for reducing ileus after surgery.A prospective multicentre cohort study was delivered by an international, student- and trainee-led collaborative group. Adult patients undergoing elective colorectal resection between January and April 2018 were included. The primary outcome was time to gastrointestinal recovery, measured using a composite measure of bowel function and tolerance to oral intake. The impact of NSAIDs was explored using Cox regression analyses, including the results of a c…

Malerenal failureTime Factorsmedicine.medical_treatmentAdult; Aged; Anti-Inflammatory Agents Non-Steroidal; Elective Surgical Procedures; Female; Humans; Ileus; Kaplan-Meier Estimate; Male; Middle Aged; Patient Safety; Postoperative Care; Postoperative Complications; Proportional Hazards Models; Prospective Studies; Recovery of Function; Time Factors; Treatment Outcome; Colectomy; ProctectomyAnti-Inflammatory Agentscolorectal surgery; ileus; non-steroidal anti-inflammatory drugs; NSAIDSKaplan-Meier Estimate030230 surgeryTumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14]0302 clinical medicinePostoperative ComplicationsProspective StudiesProspective cohort studyColectomyColorectalColectomyRISKProctectomyHazard ratioAnti-Inflammatory Agents Non-SteroidalAcute kidney injuryMiddle AgedColorectal surgeryNSAIDTreatment OutcomeElective Surgical Procedures030220 oncology & carcinogenesisFemalePatient SafetyNon-SteroidalCohort studyAdultcolorectal Surgery ileus non-steroidal anti-inflammatory drugsmedicine.medical_specialtyIleusNon‐steroidal anti‐inflammatory drugs. NSAIDs. Postoperative ileus. Colorectal surgery.ACUTE KIDNEY INJURYanti-inflammatory agents03 medical and health sciencesIleusInternal medicinemedicineHumansAdverse effectAgedProportional Hazards Modelsnon-steroidal anti-inflammatory drugs - ileus - colorectal surgeryPostoperative Carebusiness.industryRecovery of Functionmedicine.diseaseSettore MED/18 - Chirurgia Generalecolorectal cancer.Surgerycolorectal surgerybusiness
researchProduct

Benefit of weight bosed dosoges of Ribavirin (RBV) in combinotion with Peg-lnterferon (PeglFN) a2a in naive patients with HCV2 and HCV3: results of a…

2012

TreatmentPeg-InterferonGenotypesChronic Hepatitis C
researchProduct

Search for anomaly-mediated supersymmetry breaking with the ATLAS detector based on a disappearing-track signature in $pp$ collisions at $\sqrt{s}=7$…

2012

In models of anomaly-mediated supersymmetry breaking (AMSB), the lightest chargino is predicted to have a lifetime long enough to be detected in collider experiments. This letter explores AMSB scenarios in pp collisions at s√=7 TeV by attempting to identify decaying charginos which result in tracks that appear to have few associated hits in the outer region of the tracking system. The search was based on data corresponding to an integrated luminosity of 1.02 fb[superscript −1] collected with the ATLAS detector in 2011. The pT spectrum of candidate tracks is found to be consistent with the expectation from Standard Model background processes and constraints on the lifetime and the production…

Physics and Astronomy (miscellaneous)01 natural sciencesmediation: anomasymmetry breaking [supersymmetry]MASS-DEGENERATElaw.inventionHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)Charginolawscattering [p p][PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]GENERATORSanoma [mediation]supersymmetry: symmetry breakingDetectors de radiacióPhysicsddc:539Luminosity (scattering theory)PIONSSettore FIS/01 - Fisica SperimentaleSUPERGAUGE TRANSFORMATIONSATLASSupersymmetry breakingmedicine.anatomical_structurePhysical SciencesComputingMethodologies_DOCUMENTANDTEXTPROCESSINGFísica nuclearLHCParticle Physics - ExperimentParticle physicsp p: scatteringCiências Naturais::Ciências Físicas:Ciências Físicas [Ciências Naturais]FOS: Physical sciencesddc:500.2530Partícules (Física nuclear)Standard ModelCHARGINOSNuclear physicsPionAtlas (anatomy)0103 physical sciencesmedicineFysikddc:530High Energy Physics010306 general physicsColliderEngineering (miscellaneous)Science & Technology010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyFísicaATLAS detector; anomaly-mediated supersymmetry breakingMODELCol·lisions (Física nuclear)Experimental High Energy PhysicsHigh Energy Physics::ExperimentAnomaly (physics)
researchProduct

Safety of hospital discharge before return of bowel function after elective colorectal surgery

2020

Ileus is common after colorectal surgery and is associated with an increased risk of postoperative complications. Identifying features of normal bowel recovery and the appropriateness for hospital discharge is challenging. This study explored the safety of hospital discharge before the return of bowel function.A prospective, multicentre cohort study was undertaken across an international collaborative network. Adult patients undergoing elective colorectal resection between January and April 2018 were included. The main outcome of interest was readmission to hospital within 30 days of surgery. The impact of discharge timing according to the return of bowel function was explored using multiva…

operativeMalepostoperative dischargePostoperative Complications0302 clinical medicineColostomyCRITERIAProspective StudiesBowel functionColectomyIMAGINEstomaintestinesProctectomyIleostomydigestive oral and skin physiologypatient dischargecolorectal surgery hospital discharge bowel functionRECOVERYMiddle Agedadult; colostomy; elective surgical procedures; female; follow-up studies; humans; ileostomy; ileus; male; middle aged; multivariate analysis; patient discharge; patient readmission; patient safety; postoperative complications; prospective studies; recovery of function; colectomy; proctectomyPatient DischargeColorectal surgeryileus - - discharge - bowel function - elective - colorectal surgeryElective Surgical Procedures030220 oncology & carcinogenesisFemale030211 gastroenterology & hepatologyPatient SafetyCohort studysafetyAdultmedicine.medical_specialtyIleusPatient Readmissiondefecation03 medical and health sciencesIleuspostoperative complicationsmedicineHospital dischargeHumanscolorectal surgery; postoperative discharge; IMAGINE; stomacolorectal resectionColorectal resectiondefecation postoperative complications colorectal surgery intestines patient discharge patient readmission safety surgical procedures operative colorectal resection ileusbusiness.industryRecovery of FunctionOdds ratiomedicine.diseasedigestive system diseasessurgical proceduresSurgeryMultivariate AnalysisDefecationcolorectal surgerySurgerybusinessFollow-Up Studies
researchProduct

Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

2020

PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19–free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a …

MaleCancer ResearchOutcome AssessmentInternational CooperationSettore MED/18 - CHIRURGIA GENERALESettore MED/19 - Chirurgia Plastica030230 surgeryAged; Aged 80 and over; COVID-19; Cohort Studies; Critical Care; Elective Surgical Procedures; Epidemics; Female; Humans; International Cooperation; Logistic Models; Male; Middle Aged; Neoplasms; Outcome Assessment Health Care; Postoperative Complications; SARS-CoV-2Cohort Studies0302 clinical medicineOperating theaterPostoperative Complicationscohort studiesNeoplasmsHealth caremiddle agedOutcome Assessment Health Care80 and overMedicineLungCancerCOVID-19/epidemiologyAged 80 and overOUTCOMESManchester Cancer Research CentrePulmonary ComplicationORIGINAL REPORTSMiddle AgedagedOncologyElective Surgical Procedures030220 oncology & carcinogenesisPneumonia & InfluenzaFemalePatient SafetyElective Surgical ProcedureLife Sciences & Biomedicine6.4 SurgeryCohort studyHumanmedicine.medical_specialtyelective surgical procedures/methodsLogistic ModelCritical CareAged; Aged; 80 and over; COVID-19; Cohort Studies; Critical Care; Elective Surgical Procedures; Epidemics; Female; Humans; International Cooperation; Logistic Models; Male; Middle Aged; Neoplasms; Outcome Assessment; Health Care; Postoperative Complications; SARS-CoV-2Clinical SciencesOncology and CarcinogenesisEpidemic[SDV.CAN]Life Sciences [q-bio]/Cancer-.cancer surgery ; COVID-19 ; SARS-CoV-2 pandemicepidemicsCOVIDSurg CollaborativeNOoutcome assessment health care/methods03 medical and health sciencesmaleSettore MED/28 - Malattie OdontostomatologicheClinical ResearchHumans1112 Oncology and CarcinogenesisOncology & CarcinogenesisElective surgeryEpidemicsElective Cancer Surgery in SARS-CoV-2 Elective Cancer Surgery in COVID-19 covid 19 sars-cov-2AgedScience & TechnologyElective Surgical Procedurebusiness.industrySARS-CoV-2PreventionResearchInstitutes_Networks_Beacons/mcrcEvaluation of treatments and therapeutic interventionsCOVID-191103 Clinical SciencesPneumoniaOdds ratiomedicine.diseaseHealth CarePneumoniaGood Health and Well Beingneoplasms/surgeryLogistic Modelscritical care/methodsEmergency medicinepostoperative complications/prevention & controlNeoplasmPostoperative ComplicationCohort Studiebusinessaged 80 and overSARS-CoV-2/physiologylogistic models
researchProduct

Elastografia: princìpi ed applicazioni epatiche

2013

Elastografia epatopatie principi fisici
researchProduct

Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic

2021

Association of Surgeons in Training Surgical Summit, online, 17 Oct 2020 - 17 Oct 2020 2021 Virtual Annual Meeting / Surgical Research Society, online, 24 Mar 2021 - 25 Mar 2021, National Research Collaborative Meeting, online, 10 Dec 2020 - 10 Dec 2020, Royal Australasian College of Surgeons Annual Academic Surgery Conference, online, 5 Nov 2020 - 5 Nov 2020; The British journal of surgery : BJS 108(12), 1448-1464 (2021). doi:10.1093/bjs/znab336

MaleRespiration Artificial/statistics & numerical dataSettore MED/18 - CHIRURGIA GENERALEeducation-Sciences du Vivant [q-bio]/Médecine humaine et pathologieAbdominal NeoplasmPostoperative Complications/mortalityNOsurgeryCohort Studies03 medical and health sciencesCOVID-19; death; SARS-CoV-2; surgery0302 clinical medicinePostoperative ComplicationsdeathHumans030212 general & internal medicinePandemicsAbdominal Neoplasms/surgeryAgedLS7_4COVID-19/mortalityRespiratory Distress SyndromePandemicSARS-CoV-2Respirationsurgical procedures operativemortalitysurgery specialtypandemicspulmonary complicationssars-cov-2covid-19coronavirus pandemicCOVID-19Middle Aged3126 Surgery anesthesiology intensive care radiologyRespiration Artificialsurgical proceduresoperativemortalitysurgery specialtypandemicspulmonary complicationssars-cov-2covid-19coronavirus pandemicAbdominal Neoplasms; Aged; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Pandemics; Postoperative Complications; Respiration Artificial; Respiratory Distress Syndrome; Elective Surgical ProceduresElective Surgical Procedures030220 oncology & carcinogenesisAbdominal NeoplasmsArtificialFemalePostoperative ComplicationCohort Studie[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyRespiratory Distress Syndrome/mortalityHuman
researchProduct

Search for supersymmetry in events with large missing transverse momentum, jets, and at least one tau lepton in 7 TeV proton-proton collision data wi…

2012

A search for supersymmetry (SUSY) in events with large missing transverse momentum, jets, and at least one hadronically decaying τ lepton, with zero or one additional light lepton (e/μ), has been performed using 4.7 fb[superscript −1] of proton-proton collision data at √s = 7 TeV recorded with the ATLAS detector at the Large Hadron Collider. No excess above the Standard Model background expectation is observed and a 95 % confidence level visible cross-sectionupper limit for new phenomena is set. In the framework of gauge-mediated SUSY-breaking models, lower limits on the mass scale Λ are set at 54 TeV in the regions where the [bar over τ]1 is the next-to-lightest SUSY particle (tanβ > 20). …

CollisionPhysics and Astronomy (miscellaneous)Atlas detectorLarge hadron colliderNuclear physicsE(+)E(-) CollisionsParameter space7. Clean energy01 natural sciencesHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)ExtensionNaturvetenskap[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Detectors and Experimental TechniquesDetectors de radiacióTransverse momentumddc:539PhysicsLarge Hadron ColliderAtlas (topology)PhysicsSettore FIS/01 - Fisica SperimentaleParticle physicsSupersymmetryATLASTransverse momentumComputingMethodologies_DOCUMENTANDTEXTPROCESSINGFísica nuclearLHCNatural SciencesParticle Physics - ExperimentParticle physicsCiências Naturais::Ciências FísicasAtlas detectorSupergauge Transformations:Ciências Físicas [Ciências Naturais]FOS: Physical sciencesddc:500.2530Partícules (Física nuclear)LeptonNuclear physicsParameter space0103 physical sciencesddc:530High Energy PhysicsEngineering (miscellaneous); Physics and Astronomy (miscellaneous)010306 general physicsEngineering (miscellaneous)Hadron-Hadron ScatteringScience & Technology010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyFísicaQC0793Breaking TopologiesCollisionCollaborationGeneratorsOf-Mass EnergiesHADRON-HADRON COLLISIONSRoot-S=7 TevCol·lisions (Física nuclear)Experimental High Energy PhysicsHigh Energy Physics::ExperimentSupersymmetryModelLepton
researchProduct

Measurement of the Lund jet plane using charged particles in 13 TeV proton-proton collisions with the ATLAS detector

2020

The prevalence of hadronic jets at the LHC requires that a deep understanding of jet formation and structure is achieved in order to reach the highest levels of experimental and theoretical precision. There have been many measurements of jet substructure at the LHC and previous colliders, but the targeted observables mix physical effects from various origins. Based on a recent proposal to factorize physical effects, this Letter presents a double-differential cross-section measurement of the Lund jet plane using 139  fb−1 of √s=13  TeV proton-proton collision data collected with the ATLAS detector using jets with transverse momentum above 675 GeV. The measurement uses charged particles to ac…

:Kjerne- og elementærpartikkelfysikk: 431 [VDP]Protonshowers [parton]13000 GeV-cmsPhysics::Instrumentation and DetectorsHadronGeneral Physics and Astronomyjet: transverse momentumPhysical Effects01 natural sciencestransverse momentum [jet]High Energy Physics - ExperimentSubatomär fysikHigh Energy Physics - Experiment (hep-ex)Charged ParticlesSubatomic PhysicsComputingMilieux_COMPUTERSANDEDUCATIONscattering [p p][PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Parton showerNuclear ExperimentGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)PhysicsSettore FIS/01Jet (fluid)Large Hadron ColliderDouble Differential Cross SectionsDetectorhadronic [jet]Monte Carlo [numerical calculations]ATLASTransverse Momentacharged particleCharged particlemedicine.anatomical_structureCERN LHC Coll:Nuclear and elementary particle physics: 431 [VDP]colliding beams [p p]numerical calculations: Monte CarloParticle Physics - Experimentp p: scatteringCiências Naturais::Ciências Físicas530 Physicsformation [jet]Astrophysics::High Energy Astrophysical Phenomena:Ciências Físicas [Ciências Naturais]FOS: Physical sciencesMeasurements ofLHC ATLAS High Energy Physicsjet: formation530GeneralLiterature_MISCELLANEOUSMonte Carlo Modelparton: showersNuclear physicsdifferential cross section: measuredAtlas (anatomy)Fragmentationmeasured [differential cross section]0103 physical sciencesmedicineddc:530High Energy Physicsstructure010306 general physicsATLAS CollaborationScience & Technology010308 nuclear & particles physicsComputerSystemsOrganization_COMPUTER-COMMUNICATIONNETWORKSFísicajet: hadronic530 Physikangular resolutionProton Proton CollisionsElementary Particles and FieldsHigh Energy Physics::ExperimentDetector EffectsHadron-hadron collisionsp p: colliding beamsMathematicsofComputing_DISCRETEMATHEMATICSacceptanceexperimental results
researchProduct

Improved luminosity determination in pp collisions at root s=7 TeV using the ATLAS detector at the LHC

2013

The luminosity calibration for the ATLAS detector at the LHC during pp collisions at sqrt(s) = 7 TeV in 2010 and 2011 is presented. Evaluation of the luminosity scale is performed using several luminosity-sensitive detectors, and comparisons are made of the long-term stability and accuracy of this calibration applied to the pp collisions at sqrt(s) = 7 TeV. A luminosity uncertainty of Delta L/L = +/- 3.5% is obtained for the 47 pb-1 of data delivered to ATLAS in 2010, and an uncertainty of Delta L/L = +/- 1.8% is obtained for the 5.5 fb-1 delivered in 2011.

Particle physicsPhysics and Astronomy (miscellaneous)530 PhysicsAtlas detectorPhysics::Instrumentation and DetectorsAstrophysics::High Energy Astrophysical PhenomenaFOS: Physical sciencesAstrophysics::Cosmology and Extragalactic AstrophysicsInteraction-Point01 natural sciencesHigh Energy Physics - ExperimentNuclear physicsHigh Energy Physics - Experiment (hep-ex)Atlas (anatomy)0103 physical sciencesmedicineCalibration[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Fysikddc:530High Energy Physics010306 general physicsNuclear ExperimentGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)Engineering (miscellaneous)PhysicsLarge Hadron ColliderLuminosity (scattering theory)Sensors010308 nuclear & particles physicsSettore FIS/01 - Fisica SperimentaleDetectorFísicaBeamATLASmedicine.anatomical_structureExperimental High Energy PhysicsPhysical SciencesHigh Energy Physics::ExperimentLHCParticle Physics - Experiment
researchProduct

Delaying surgery for patients with a previous SARS-CoV-2 infection

2020

With at least 28 elective million operations delayed during the first three months of the COVID-19 pandemic, the number of patients who will require surgery after a previous SARS-CoV-2 infection is likely to increase rapidly1. Operating on patients with an active perioperative SARS-CoV-2 infection is now known to carry a very high pulmonary complication and mortality rate2. Urgent information is needed to guide whether postponing surgery in patients with a previous SARS-CoV-2 infection leads to a clinical benefit, and the optimal length of delay.

SARS Virus Coronavirus Severe Acute Respiratory Syndrome cancersurgery pandemic infectionSettore MED/06 - Oncologia MedicaSettore MED/18 - CHIRURGIA GENERALESettore MED/29 - CHIRURGIA MAXILLOFACCIALECOVID-19. Global surgery.Settore MED/19 - Chirurgia PlasticaComorbidity030230 surgeryCovidCOVID-19 / epidemiologysurgery0302 clinical medicineNeoplasms / surgeryNeoplasmsCOVID-19; Comorbidity; Humans; Neoplasms; Surgical Procedures Operative; Pandemics; SARS-CoV-2; Time-to-TreatmentProspective cohort study610 Medicine & healthCOVID-19/epidemiologymedicine.diagnostic_testSurgery sars-cov-2 covid surg surgery pandemic infectionPulmonary ComplicationSARS cov 2Covid19Surgical Procedures Operative / methodsOperativesurgery; Sars-CoV-2Surgical Procedures OperativeSurgery sars-cov-2Neoplasms / epidemiologyCohort studyHumanmedicine.medical_specialtySciences du Vivant [q-bio]/Médecine humaine et pathologieNOTime-to-TreatmentThroat culture03 medical and health sciencesSettore MED/28 - Malattie OdontostomatologichemedicineResearch LetterHumansElective surgeryGeneralPandemicscovid surgSurgical ProceduresPandemicbusiness.industrySARS-CoV-2No key words availablePostoperative complicationCOVID-19Perioperativemedicine.diseaseSurgeryPneumoniaSettore MED/40 - GINECOLOGIA E OSTETRICIANeoplasmSurgical Procedures Operative/methodsSurgerybusinessNeoplasms/epidemiology[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with differe…

2016

OBJECTIVES: This study aims to evaluate the reliability and clinical utility of NS3 sequencing in hepatitis C virus (HCV) 1-infected patients who were candidates to start a PI-containing regimen. METHODS: NS3 protease sequencing was performed by in-house-developed HCV-1 subtype-specific protocols. Phylogenetic analysis was used to test sequencing reliability and concordance with previous genotype/subtype assignment by commercial genotyping assays. RESULTS: Five hundred and sixty-seven HCV plasma samples with quantifiable HCV-RNA from 326 HCV-infected patients were collected between 2011 and 2014. Overall, the success rate of NS3 sequencing was 88.9%. The success rate between the two subtype…

0301 basic medicinens3Genotyping TechniquesvirusesDrug ResistanceHepacivirusViral Nonstructural Proteinsmedicine.disease_causeGastroenterologyTelaprevirchemistry.chemical_compoundgenotype; genotyping techniques; hepacivirus; hepatitis C; humans; RNA viral; retrospective studies; sequence analysis; DNA; viral nonstructural proteins; drug resistance viral; mutation; pharmacology; infectious diseases0302 clinical medicineRetrospective StudieGenotypePharmacology (medical)ViralGenotype; Genotyping Techniques; Hepacivirus; Hepatitis C; Humans; RNA Viral; Retrospective Studies; Sequence Analysis DNA; Viral Nonstructural Proteins; Drug Resistance Viral; MutationProteolytic enzymesvirus diseasesSettore MED/07 - Microbiologia e Microbiologia ClinicaHepatitis Chcv-rna levelsInfectious DiseasesHCV-RNARNA Viral030211 gastroenterology & hepatologySequence Analysismedicine.drugHumanMicrobiology (medical)medicine.medical_specialtyGenotypeHepatitis C virusConcordanceSettore MED/12 - GASTROENTEROLOGIAGenotype; Genotyping Techniques; Hepacivirus; Hepatitis C; Humans; RNA Viral; Retrospective Studies; Sequence Analysis DNA; Viral Nonstructural Proteins; Drug Resistance Viral; Mutation; Pharmacology; Pharmacology (medical); Infectious DiseasesBiology03 medical and health sciencesBoceprevirInternal medicineDrug Resistance ViralmedicinehcvHumansGenotypingGenotyping TechniquesRetrospective StudiesPharmacologyHepaciviruViral Nonstructural ProteinSettore MED/09 - MEDICINA INTERNASequence Analysis DNADNAVirologydigestive system diseases030104 developmental biologychemistrySequence AnalysiMutationRNAGenotyping TechniqueRNA viral
researchProduct

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately …

2017

Background The best treatment option for patients with type 2 diabetes in whom treatment with metformin alone fails to achieve adequate glycaemic control is debated. We aimed to compare the long-term effects of pioglitazone versus sulfonylureas, given in addition to metformin, on cardiovascular events in patients with type 2 diabetes. Methods TOSCA.IT was a multicentre, randomised, pragmatic clinical trial, in which patients aged 50–75 years with type 2 diabetes inadequately controlled with metformin monotherapy (2–3 g per day) were recruited from 57 diabetes clinics in Italy. Patients were randomly assigned (1:1), by permuted blocks randomisation (block size 10), stratified by site and…

MaleDiabetes and Metabolism ipoglycemic drugs cardiovascualr eventSettore MED/09 - Medicina Internaendocrine system diseasesIMPACTpioglitazone versus sulfonylureasEndocrinology Diabetes and MetabolismGLIMEPIRIDEDiabetes cardiovascular events metformin pioglitazone sulphonylureasType 2 diabetes030204 cardiovascular system & hematologyInternal Medicine; Endocrinology Diabetes and Metabolism; Endocrinologylaw.inventionSettore MED/13 - EndocrinologiaGlibenclamide0302 clinical medicineRandomized controlled triallawGLYCEMIC CONTROLGliclazideInternal medicinediabetes and metabolismRISKeducation.field_of_studydiabetesIncidenceInternal medicine; endocrinology diabetes and metabolism; endocrinologyMiddle AgedINSULINMetforminMetforminTreatment OutcomeEditorialsulphonylureasCardiovascular DiseasesCombinationDrug Therapy CombinationFemaleType 2medicine.drugmedicine.medical_specialtyPopulation030209 endocrinology & metabolismAged; Cardiovascular Diseases; Diabetes Mellitus Type 2; Drug Therapy Combination; Female; Humans; Hypoglycemic Agents; Incidence; Male; Metformin; Middle Aged; Pioglitazone; Sulfonylurea Compounds; Thiazolidinediones; Treatment OutcomeCardiovascular events03 medical and health sciencesendocrinologyGLUCOSE-LOWERING DRUGSDrug TherapyInternal medicineDiabetes MellitusmedicineHumansHypoglycemic AgentssulfonylureaseducationTOSCA.ITAgedPioglitazonebusiness.industryMORTALITYnutritional and metabolic diseasesInsulin resistancemedicine.diseaseSurgeryGlimepirideSulfonylurea CompoundsDiabetes Mellitus Type 2Diabetes Mellitus; Pioglitazone; Insulin resistanceThiazolidinedionesbusinessFOLLOW-UPPioglitazone
researchProduct

Search for light scalar top quark pair production in final states with two leptons with the ATLAS detector in sqrt(s) = 7 TeV proton-proton collisions

2012

A search is presented for the pair production of light scalar top quarks in s√=7 TeV proton–proton collisions recorded with the ATLAS detector at the Large Hadron Collider. This analysis uses the full data sample collected during 2011 running that corresponds to a total integrated luminosity of 4.7 fb[superscript −1]. Light scalar top quarks are searched for in events with two opposite-sign leptons (e, μ), large missing transverse momentum and at least one jet in the final state. No excess over Standard Model expectations is found, and the results are interpreted under the assumption that the light scalar top decays to a b-quark in addition to an on-shell chargino whose decay occurs through…

Top quarkPhysics and Astronomy (miscellaneous)7. Clean energy01 natural sciencesHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)CharginoPionsNaturvetenskap[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]WeakNuclear ExperimentDetectors de radiacióQCddc:539PhysicsLarge Hadron ColliderSettore FIS/01 - Fisica SperimentaleATLASComputingMethodologies_DOCUMENTANDTEXTPROCESSINGFísica nuclearLHCNatural SciencesParticle Physics - ExperimentQuarkParticle physicsleptonsCiências Naturais::Ciências FísicasSupergauge Transformations:Ciências Físicas [Ciências Naturais]FOS: Physical sciencesddc:500.2530Partícules (Física nuclear)Nuclear physicsPionCurrents0103 physical sciencesddc:530High Energy PhysicsEngineering (miscellaneous); Physics and Astronomy (miscellaneous)010306 general physicsEngineering (miscellaneous)Ciencias ExactasHadron-Hadron ScatteringScience & TechnologyATLAS detector010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyFísicaPair productionHADRON-HADRON COLLISIONSCol·lisions (Física nuclear)Experimental High Energy Physicsproton-proton collisionsHigh Energy Physics::ExperimentSupersymmetryModelMinimal Supersymmetric Standard ModelLepton
researchProduct

Search for supersymmetry in events with photons, bottom quarks, and missing transverse momentum in proton-proton collisions at a centre-of-mass energ…

2013

A search has been performed for the experimental signature of an isolated photon with high transverse momentum, at least one jet identified as originating from a bottom quark, and high missing transverse momentum. Such a final state may originate from supersymmetric models with gauge-mediated supersymmetry breaking in events in which one of a pair of higgsino-like neutralinos decays into a photon and a gravitino while the other decays into a Higgs boson and a gravitino. The search is performed using the full dataset of 7 TeV proton–proton collisions recorded with the ATLAS detector at the LHC in 2011, corresponding to an integrated luminosity of 4.7 fb−1. A total of 7 candidate events are o…

gauge mediationNuclear Theory7. Clean energy01 natural sciencesHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)Naturvetenskap[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Nuclear ExperimentQCPhysicsLarge Hadron ColliderSettore FIS/01 - Fisica SperimentaleSupersymmetryATLASSupersymmetry breakingComputingMethodologies_DOCUMENTANDTEXTPROCESSINGHiggs bosonGravitinoFísica nuclearLHCNatural SciencesParticle Physics - ExperimentQuarksupersymmetry; higgs boson; gauge mediationParticle physicsNuclear and High Energy PhysicsCiências Naturais::Ciências Físicas530 PhysicsHiggs boson:Ciências Físicas [Ciências Naturais]FOS: Physical sciencesddc:500.2530Bottom quarkhiggs bosonNuclear physics0103 physical sciencesddc:530High Energy Physics010306 general physicsScience & Technology010308 nuclear & particles physicsHigh Energy Physics::PhenomenologySupersymmetry; Gauge mediation; Higgs boson; Atlas detectorGauge mediationHADRON-HADRON COLLISIONSExperimental High Energy PhysicsNeutralinoPhysics::Accelerator PhysicsHigh Energy Physics::ExperimentSupersymmetrysupersymmetry
researchProduct

Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

2020

Background: In allergic rhinitis, a relevant outcome providing information on the effectiveness of interventions is needed. In MASK-air (Mobile Airways Sentinel Network), a visual analogue scale (VAS) for work is used as a relevant outcome. This study aimed to assess the performance of the work VAS work by comparing VAS work with other VAS measurements and symptom-medication scores obtained concurrently. Methods: All consecutive MASK-air users in 23 countries from 1 June 2016 to 31 October 2018 were included (14 189 users; 205 904 days). Geolocalized users self-assessed daily symptom control using the touchscreen functionality on their smart phone to click on VAS scores (ranging from 0 to 1…

0301 basic medicineSYMPTOMSSmart phoneAllergyEscala visual analógicaINNOVATION[SDV]Life Sciences [q-bio]Medical and Health SciencesCorrelationvisual analogue scale0302 clinical medicineQuality of lifeVisual analogue scaleQUALITY-OF-LIFEMàscaresImmunology and AllergyscoreNoseRinitisRhinitisPRODUCTIVITY COSTSasthma; MASK; rhinitis; score; visual analogue scaleScoreExplained variationResponse VariabilityMobile ApplicationsALLERGIC RHINITISrhinitimedicine.anatomical_structureTRIALSRinite1107 Immunology[SDV.IMM]Life Sciences [q-bio]/ImmunologySmartphonemedicine.medical_specialtyMASKVisual analogue scaleMASK study groupImmunologyMACVIA-ARIA03 medical and health sciencesAllergicrhinitismedicineHumansvisual analogue scale.TECHNOLOGYIMMUNOTHERAPYAsmaAsthmabusiness.industryasthma; MASK; rhinitis; score; visual analogue scale; Humans; Smartphone; Asthma; Mobile Applications; Rhinitis; Rhinitis Allergicasthmamedicine.diseaseRhinitis AllergicAsthmaRHINOCONJUNCTIVITIS030104 developmental biology030228 respiratory system3121 General medicine internal medicine and other clinical medicinePhysical therapyClinical Medicinebusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Search for pair-produced massive coloured scalars in four-jet final states with the ATLAS detector in proton–proton collisions at √s =7 TeV

2013

A search for pair-produced massive coloured scalar particles decaying to a four-jet final state is performed by the ATLAS experiment at the LHC in proton–proton collisions at √s = 7 TeV. The analysed data sample corresponds to an integrated luminosity of 4.6 fb[superscript −1]. No deviation from the Standard Model is observed in the invariant mass spectrum of the two-jet pairs. A limit on the scalar gluon pair production cross section of 70 pb (10 pb) is obtained at the 95 % confidence level for a scalar gluon mass of 150 GeV (350 GeV). Interpreting these results as mass limits on scalar gluons, masses ranging from 150 GeV to 287 GeV are excluded at the 95 % confidence level.

Physics and Astronomy (miscellaneous)7. Clean energy01 natural sciencesHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)Naturvetenskap[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Invariant massNuclear ExperimentQCPhysicsLarge Hadron ColliderSettore FIS/01 - Fisica SperimentaleATLAS experimentSupersymmetryATLAS:Mathematics and natural scienses: 400::Physics: 430::Nuclear and elementary particle physics: 431 [VDP]ParityComputingMethodologies_DOCUMENTANDTEXTPROCESSINGFísica nuclearLHCNeutrinoNatural SciencesParticle Physics - ExperimentParticle physicsCiências Naturais::Ciências Físicas530 PhysicsAstrophysics::High Energy Astrophysical Phenomena:Ciências Físicas [Ciências Naturais]Scalar (mathematics)FOS: Physical sciencesddc:500.2530Nuclear physics0103 physical sciencesddc:530High Energy PhysicsNeutrinos010306 general physicsEngineering (miscellaneous); Physics and Astronomy (miscellaneous)Engineering (miscellaneous)Science & TechnologyHadron-Hadron Scattering010308 nuclear & particles physics:Matematikk og naturvitenskap: 400::Fysikk: 430::Kjerne- og elementærpartikkelfysikk: 431 [VDP]FísicaNeutrino massesGluonPair productionExperimental High Energy PhysicsHigh Energy Physics::ExperimentSupersymmetry
researchProduct

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

2021

This international, prospective, cohort study enrolled 20 006 adult (≥18 years) patients from 466 hospitals in 61 countries with 15 cancer types, who had a decision for curative surgery during the COVID-19 pandemic and were followed up until the point of surgery or cessation of follow-up (Aug 31, 2020). Average national Oxford COVID-19 Stringency Index scores were calculated to define the government response to COVID-19 for each patient for the period they awaited surgery, and classified into light restrictions (index 60). The primary outcome was the non-operation rate (defined as the proportion of patients who did not undergo planned surgery). Cox proportional-hazards regression models wer…

MaleCOVID-19 COVIDSURG COVIDSURG CANCEROutcome AssessmentIMPACTSettore MED/18 - CHIRURGIA GENERALEBIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Surgery.surgeryCancer surgeryNeoplasms/classificationBIOMEDICINA I ZDRAVSTVO. Javno zdravstvo i zdravstvena zaštita.Surgical oncologyNeoplasmsAcute careCOVID-19 - epidemiologyOutcome Assessment Health CareMedicine and Health Sciences80 and overGlobal healthtimingProspective StudiesUK610 Medicine & healthProspective cohort studyCOVID-19/epidemiologyCOVIDAged 80 and overBIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Oncology.BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Kirurgija.Hazard ratioArticlesMiddle AgedOncologyAdult; Aged; Aged 80 and over; Communicable Disease Control; COVID-19; Female; Humans; Male; Middle Aged; Neoplasms; Outcome Assessment Health Care; Proportional Hazards Models; Prospective Studies; SARS-CoV-2; Time-to-Treatment; Withholding Treatment/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemalecancer surgeryCovid-19Life Sciences & BiomedicineMENTAL-HEALTHmental healthCohort studyHumanAdultmedicine.medical_specialtydelay3122 CancersCOVID-19 - prevention and control610 Medicine & healthCOVIDSurg CollaborativeNOTime-to-TreatmentSDG 3 - Good Health and Well-beingLockdownmedicineHumanscancer1112 Oncology and CarcinogenesisOncology & CarcinogenesisElective surgeryLS7_4Proportional Hazards ModelsAgedScience & Technologybusiness.industrySARS-CoV-2Public healthGeneral surgeryBIOMEDICINE AND HEALTHCARE. Public Health and Health Care.COVID-193126 Surgery anesthesiology intensive care radiologyHealth CareCommunicable Disease Control/legislation & jurisprudenceProspective StudieWithholding TreatmentCOVID-19; delay; SARS-CoV-2; surgery; timing; cancer surgery;COVID-19 ; lockdowns ; cancer surgeryCommunicable Disease ControlBIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Onkologija.Proportional Hazards ModelNeoplasmbusiness
researchProduct

Epatopatie diffuse

2013

Ecografia epatopatie
researchProduct

Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pand…

2021

Abstract Background Surgical services are preparing to scale up in areas affected by COVID-19. This study aimed to evaluate the association between preoperative SARS-CoV-2 testing and postoperative pulmonary complications in patients undergoing elective cancer surgery. Methods This international cohort study included adult patients undergoing elective surgery for cancer in areas affected by SARS-CoV-2 up to 19 April 2020. Patients suspected of SARS-CoV-2 infection before operation were excluded. The primary outcome measure was postoperative pulmonary complications at 30 days after surgery. Preoperative testing strategies were adjusted for confounding using mixed-effects models. Results Of 8…

Lung DiseasesMalexAcademicSubjects/MED00910COVID-19/diagnosisSettore MED/18 - CHIRURGIA GENERALEneoplasms030230 surgeryminorsurgical proceduresMedical and Health SciencesLung Disease0302 clinical medicinePostoperative Complications030202 anesthesiologyaged; aged 80 and over; COVID-19; elective surgical procedures; female; humans; lung diseases; male; middle aged; Nasopharynx; neoplasms; pandemics; postoperative complications; risk assessment; SARS-CoV-2; COVID-19 nucleic acid testingNeoplasmsNasopharynx80 and over030212 general & internal medicine610 Medicine & healthLungCancerlung diseasesAged 80 and overIncidence (epidemiology)ConfoundingPulmonary ComplicationLung Diseases/*etiologyNeoplasms/surgeryGeneral MedicineMiddle AgedElective Surgical Procedures/adverse effectsOncologyElective Surgical Procedures030220 oncology & carcinogenesisCOVID-19 Nucleic Acid TestingOriginal ArticleFemalePatient SafetyAcademicSubjects/MED00010Elective Surgical Procedure6.4 SurgeryHumanCohort studymedicine.medical_specialtypreoperative caresurgical proceduresCOVID-19 nucleic acid testing.elective surgical proceduresPreoperative careRisk AssessmentArticleCOVIDSurg CollaborativeNO*COVID-19 Nucleic Acid TestingVaccine Related03 medical and health sciencesClinical ResearchBiodefensemedicineNasopharynx/*virologyHumansNasopharynx/virologyElective surgeryAdverse effectPandemicsLS7_4AgedElective Surgical ProcedurePandemicbusiness.industrySARS-CoV-2Surgery Sars Cov2PreventionNo key words availableelectivesurgical proceduresLung Diseases/etiologyEvaluation of treatments and therapeutic interventionsCancerPostoperative complicationoperativenasopharynxsurgery specialtypulmonary complicationscancer surgerysars-cov-2covid-19coronavirus pandemicCOVID-19Odds ratiomedicine.diseaseConfidence intervalSurgeryCOVID-19/*diagnosisEmerging Infectious DiseasesGood Health and Well BeingNeoplasmSurgeryPostoperative Complicationpreoperative caresurgical procedures electivesurgical procedures minorsurgical procedures operativenasopharynxsurgery specialtypulmonary complicationscancer surgerysars-cov-2covid-19coronavirus pandemicElective Surgical Procedures/*adverse effectsbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Extended duration of therapy with peginterferon alpha 2b and weight based ribavirin in HCV patients with genotype 3 infection

2009

Settore MED/09 - Medicina Internatreatmenthepatitis c virugenotype 3peginterferon and ribavirin
researchProduct

Search for a heavy top-quark partner in final states with two leptons with the ATLAS detector at the LHC

2012

The results of a search for direct pair production of heavy top-quark partners in 4.7 fb[superscript −1] of integrated luminosity from pp collisions at s√ = 7 TeV collected by the ATLAS detector at the LHC are reported. Heavy top-quark partners decaying into a top quark and a neutral non-interacting particle are searched for in events with two leptons in the final state. No excess above the Standard Model expectation is observed. Limits are placed on the mass of a supersymmetric scalar top and of a spin-1/2 top-quark partner. A spin-1/2 top-quark partner with a mass between 300 GeV and 480 GeV, decaying to a top quark and a neutral non-interacting particle lighter than 100 GeV, is excluded …

Top quark01 natural sciences7. Clean energyHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Nuclear ExperimentQCPhysicsddc:539Large Hadron ColliderLuminosity (scattering theory)[SDU.ASTR.HE]Sciences of the Universe [physics]/Astrophysics [astro-ph]/High Energy Astrophysical Phenomena [astro-ph.HE]Settore FIS/01 - Fisica SperimentaleSupersymmetryATLASComputer Science::Computers and Societyhmedicine.anatomical_structurehadron-hadronComputingMethodologies_DOCUMENTANDTEXTPROCESSINGFísica nuclearLHCParticle Physics - ExperimentParticle physicsNuclear and High Energy Physics[PHYS.ASTR.HE]Physics [physics]/Astrophysics [astro-ph]/High Energy Astrophysical Phenomena [astro-ph.HE]leptonsCiências Naturais::Ciências Físicas:Ciências Físicas [Ciências Naturais]FOS: Physical sciences530Standard ModelNuclear physicsAtlas (anatomy)0103 physical sciencesmedicinePhysics::Atomic and Molecular Clustersddc:530High Energy Physics010306 general physicsCiencias ExactasHadron-Hadron scattering; Nuclear and High Energy PhysicsHadron-Hadron ScatteringScience & TechnologyATLAS detector010308 nuclear & particles physicsscatteringHigh Energy Physics::PhenomenologyFísicaPair productionNonlinear Sciences::Exactly Solvable and Integrable SystemsHADRON-HADRON COLLISIONSExperimental High Energy PhysicsHigh Energy Physics::ExperimentsupersymmetryLeptonhadron-hadron; hadron-hadron scattering; scattering
researchProduct